Viking Global Opportunities Illiquid Investments Sub-Master LP
CIK 1629482 · last filed 2024-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.09B
Companies
11
Total Filings
13
Lifetime Open-Market Net
$249.37M
Filer Profile
Reported Address
600 WASHINGTON BLVD.FLOOR 11
STAMFORD, CT 06901
Phone
(212) 672-7000
State of Incorporation
Cayman Islands
Related Filers
OLE ANDREAS HALVORSEN — 78 joint filings, latest 2025-10-09
David C. Ott — 78 joint filings, latest 2025-10-09
VIKING GLOBAL INVESTORS LP — 78 joint filings, latest 2025-10-09
Viking Global Opportunities GP LLC — 78 joint filings, latest 2025-10-09
Viking Global Opportunities Portfolio GP LLC — 78 joint filings, latest 2025-10-09
Rose Sharon Shabet — 71 joint filings, latest 2025-10-09
Viking Global Opportunities Parent GP LLC — 27 joint filings, latest 2025-10-09
BridgeBio Pharma, Inc. — 6 joint filings, latest 2025-07-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| APG | 10%+ Owner | 0 | $37.86 | $0 | -$595.68M | 1 | 2024-06-18 |
| FDMT | 10%+ Owner | 4,787,914 | $13.17 | $63.06M | $108.80M | 1 | 2023-05-11 |
| INBX | 10%+ Owner | 333,333 | $109.27 | $36.42M | $320.00M | 1 | 2022-10-12 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | 10%+ Owner | 51,055,144 | $0.01 | $321.6K | $0 | 1 | 2022-03-04 |
| AMLX | 10%+ Owner | 4,870,536 | $31.62 | $154.01M | $349.60M | 1 | 2022-01-13 |
| ZNTL | 10%+ Owner | 3,943,284 | $3.51 | $13.84M | -$176.75M | 1 | 2020-12-03 |
| ADPT | 10%+ Owner | 33,493,708 | $24.20 | $810.55M | -$858.94M | 1 | 2020-01-30 |
| Myovant Sciences Ltd. (MYOV) Delisted | 10%+ Owner | 40,765,599 | $26.98 | $1.10B | $140.00M | 1 | 2019-06-13 |
| Urovant Sciences Ltd. (UROV) Delisted | 10%+ Owner | 22,740,305 | $16.24 | $369.30M | $962.34M | 2 | 2019-05-23 |
| ABUS | 10%+ Owner | — | $5.12 | — | $0 | 1 | 2017-10-17 |
| EDIT | 10%+ Owner | 2,744,880 | $2.70 | $7.41M | $0 | 1 | 2016-02-08 |
Recent Filings · Page 2 of 2
13 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-03 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +18,749,997 | $262.50M | EDGAR |
| 2017-10-17 | ABUS | Buy (P) | — | $0 | EDGAR |
| 2016-02-08 | EDIT | Mixed | +38,217,312 | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.